Becton, Dickinson and Company BDX, popularly known as BD, recently unveiled the BD FACSDiscover A8 Cell Analyzer. This advanced platform integrates breakthrough spectral flow cytometry with real-time ...
Featured in the journal Science and unveiled at last year’s International Society for Advancement of Cytometry CYTO conference, BD‘s first-of-its-kind cell-sorting technology has now launched ...
BD demonstrated how its portfolio supports the evolving needs of pharmaceutical and biotechnology companies developing biologics – GLP-1 therapies, vaccines, and acute care medicines – as the industry ...
FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination ...
BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes
FRANKLIN LAKES, N.J., Dec. 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of new ...
On behalf of the BD+C editorial team, thank you for participating in BD+C's 2026 Giants 400 Technology and Innovation Survey. This research project is part of an ongoing effort by the BD+C editorial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results